4/20/2022 12:29:15 PM - Challenging its 52-week high with today's 6th consecutive gain. Last noted with caution in the 2/04/22 mid-day report while sputtering below its 200 DMA line following a new Public Offering completed 1/20/22 - "Quarterly and annual earnings increases have not been strong and steady above the +25% minimum guideline (C criteria)."
2/4/2022 12:08:36 PM - Still sputtering below its 200 DMA line following a new Public Offering on 1/20/22. Noted with caution in prior mid-day reports - "Quarterly and annual earnings increases have not been strong and steady above the +25% minimum guideline (C criteria)."
1/24/2022 12:31:25 PM - Gapped down again today, slumping further below its 200 DMA line ($39.83). Priced a new Public Offering, last week while pulling back from its all-time high and noted in the 1/20/22 mid-day report - "Quarterly and annual earnings increases have not been strong and steady above the +25% minimum guideline (C criteria)."
1/20/2022 12:09:45 PM - Gapped down after proposing a new Public Offering, pulling back from its all-time high. Quarterly and annual earnings increases have not been strong and steady above the +25% minimum guideline (C criteria).
12/29/2021 12:38:00 PM - Wedging into new high territory with gains lacking great volume conviction. Quarterly and annual earnings increases have not been strong and steady above the +25% minimum guideline (C criteria).